Catalyst overview
Research summary
This catalyst tracks a Phase 2 data readout for Descartes-08 in Myositis. The expected timing is based on the latest available company guidance and may change.
11/13/25- File IND by YE 2025. Initiate Ph2 trial in H1 2026. 03/09/26:- FDA accepted IND; Ph2 TRITON myositis trial initiation reiterated for H1 2026. 04/30/26:- Phase 2 TRITON myositis trial of Descartes-08 initiated; first 10 patients to guide pivotal path. 08/06/26:- TRITON Ph2 subset data expected H1 2027 to guide pivotal path.
Verification
Confirm timing and program details against the company announcement or filing.